Tips Round-Up (Premium)
Despite the sag in Durex in sales during the first half at Reckitt Benckiser's, the Mail on Sunday's Rosie Murray-West told readers to 'hold' onto the shares.
The Sunday Times's Peter Evans told readers to 'buy' shares of Whitbread as the hotel and restaurant operator prepares to reopen its establishments, but conceded that a second lockdown would be "disastrous".
The Mail on Sunday's Midas column touted the long-term potential for Gresham House, the green investor, including for its dividend payout.
The Sunday Times's Sabah Meddings told readers of her 'Inside the City' column to 'buy' shares of PureTech, citing the the drug maker's ingenious 'portfolio' approach and ample pipeline of treatments in various phases of development.
The novel coronavirus pandemic is forcing whole industries to adapt, not least healthcare and the NHS.
The Sunday Times's Sam Chambers thinks readers should 'sell' shares of Hammerson.
The Mail on Sunday's Midas column recommends that investors stick with Ideagen, pointing to software developer's big base of recurring revenues and brisk uptake of its products in the wake of the Covid-19 pandemic.
Shares of Homeserve should "continue to do well", the Mail on Sunday's Midas column said, pointing to the company's growth outlook, plans for international expansion and - above all - the drive of its founder and chief executive as the main reasons behind its confidence in the outfit.
The Sunday Times's Sabah Meddings told readers to 'buy' shares of Hikma Pharmaceuticals, touting it as a potential beneficiary of the White House's 'America First' strategy to promote US manufacturing.
The difficult outlook in almost every sense has experts believing that conditions are set fair for the price of gold, which bodes well for gold miners as well as for those working for them, such as Capital Drilling, said the Mail on Sunday's Midas column.
The Mail on Sunday's Midas column recommended readers 'buy' shares of Braemar Shipping pointing out a raft of reasons why it believed the shipping broker was deeply oversold.
Hold onto shares of Begbies Traynor, the Mail on Sunday's Midas column said, predicting that the stock would continue to rise.
The Mail on Sunday's Midas column reiterated its positive stance on stock in drug packager Mpac, highlighting the company's move into the black and its list of blue chip clients.
Morrisons decision to continue going 'the extra mile' for all its stakeholders, clients, staff and shareholders should stand it in good stead over the longer-term, the Mail on Sunday's Midas column said.
Close Brothers has several things going for in comparison to its peers, but it too faces challenges and with so much uncertainty around they are best kept at "arm's length", The Sunday Times's Emma Dunkley says.
The Mail on Sunday's Midas column believes Treatt has all the right ingredients to shareholders clean up.
Co-working is here to stay, but until it becomes clear when the lockdowns in place around the globe will be lifted, International Workplace Group (IWG) is a "stock to watch" not one to buy, the Sunday Times's Sam Chambers said.
The Sunday Times's Sabah Meddings recommends buying shares of Synairgen arguing that the Covid-19 pandemic may have given the firm a new lease on life.
The Sunday Times's 'Inside the City column' believes that the downdraft in Barratt Developments's shares is overdone.
Tristel will almost certainly benefit from demand for disinfection products amid the growing panic over the coronavirus, the Mail on Sunday's Midas column said.